1 ML atropine sulfate 0.4 MG/ML Injection
- RxCUI
- 1666781
- RxNorm name
- 1 ML atropine sulfate 0.4 MG/ML Injection
- Display name
- Atropine (Injectable)
- Full name
- 1 ML atropine sulfate 0.4 MG/ML Injection
- Term type
- SCD
- Status
- Active
- Strength
- 0.4 mg/ml
- Dose form
- Injection 1 ml
- Route
- Injectable
- Updated
- 2026-10-20 20:51:48
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102015
- Active start
- 102015
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| atropine sulfate | 0.4 MG / 1 ML | atropine | atropine sulfate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injection | 1649574 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| atropine | 1223 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | 1 ML atropine sulfate 0.4 MG/ML Injection | 1 | NAMES |
| RxNorm Name | 1 ML atropine sulfate 0.4 MG/ML Injection | 1 | NAMES |
| RxNorm Synonym | atropine sulfate 0.4 MG per 1 ML Injection | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 9 linked values
| 9 | CODES |
| RxCUI | 1666781 | 1 | CODES |
| MMSL_CODE | BD31381 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0404-9802-01 | 0404-9802 | Atropine Sulfate Atropine Sulfate | Henry Schein, Inc | ANDA216120 |
| 0517-1004-25 | 0517-1004 | Atropine Sulfate ATROPINE SULFATE | American Regent, Inc. | ANDA216120 |
| 0641-6274-25 | 0641-6274 | Atropine Sulfate Atropine Sulfate | Hikma Pharmaceuticals USA Inc. | ANDA217345 |
| 51662-1627-3 | 51662-1627 | Atropine sulfate Atropine sulfate | HF Acquisition Co LLC, DBA HealthFirst | ANDA216120 |
| 70069-631-25 | 70069-631 | Atropine Sulfate Atropine Sulfate | Somerset Therapeutics, LLC | ANDA215969 |
| 71872-7312-1 | 71872-7312 | Atropine Sulfate ATROPINE SULFATE | Medical Purchasing Solutions, LLC | ANDA216120 |
| 71872-7341-1 | 71872-7341 | Atropine Sulfate Atropine Sulfate | Medical Purchasing Solutions, LLC | ANDA215969 |
| 84549-631-25 | 84549-631 | Atropine Sulfate Atropine Sulfate | ProPharma Distribution | ANDA215969 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA216120 | 0404-9802 | Atropine Sulfate Atropine Sulfate | ANDA | Henry Schein, Inc |
| ANDA217345 | 0641-6274 | Atropine Sulfate Atropine Sulfate | ANDA | Hikma Pharmaceuticals USA Inc. |
| ANDA215969 | 70069-631 | Atropine Sulfate Atropine Sulfate | ANDA | Somerset Therapeutics, LLC |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atropine Sulfate | ATROPINE SULFATE | Henry Schein, Inc | b753894e-81f8-4e81-b07a-c338311ded5b | 2025-10-27 | Warnings, Adverse reactions | 0404-9802-01 0404-9802 00404980201 1666781 |
| Atropine Sulfate | ATROPINE SULFATE | Hikma Pharmaceuticals USA Inc. | a66eecf9-2d8b-4e2d-8a05-d718dcbc3542 | 2025-10-08 | Warnings, Adverse reactions | 0641-6274-25 0641-6274 00641627425 00641627401 1666781 |
| Atropine Sulfate | ATROPINE SULFATE | Medical Purchasing Solutions, LLC | 3fa81939-4495-28d5-e063-6394a90a1f2d | 2025-09-25 | Warnings, Adverse reactions | 71872-7341-1 71872-7341 71872734101 1666781 |
| Atropine Sulfate | ATROPINE SULFATE | ProPharma Distribution | 3eef6300-9c78-82b2-e063-6294a90a5499 | 2025-09-16 | Warnings, Adverse reactions | 84549-631-25 84549-631 84549063125 1666781 |
| Atropine Sulfate | ATROPINE SULFATE | Somerset Therapeutics, LLC | a6fac578-c7bc-4b3c-a454-7889cc819118 | 2024-07-04 | Warnings, Adverse reactions | 70069-631-25 70069-631 70069063125 70069063101 1666781 |
| Atropine sulfate | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 007728fc-f4cb-d519-e063-6394a90ae033 | 2024-01-22 | Warnings, Adverse reactions | 51662-1627-3 51662-1627 51662162702 51662162701 51662162703 1666781 |
| Atropine Sulfate | ATROPINE SULFATE | Medical Purchasing Solutions, LLC | 09d086f2-db9a-5e15-e063-6394a90abe18 | 2023-11-10 | Warnings, Adverse reactions | 71872-7312-1 71872-7312 71872731201 1666781 |
| Atropine Sulfate | ATROPINE SULFATE | American Regent, Inc. | 6fee1727-52b7-4f73-ab45-ef47d6a1c5bb | 2021-09-01 | Warnings, Adverse reactions | 0517-1004-25 0517-1004 00517100425 00517100401 1666781 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6fee1727-52b7-4f73-ab45-ef47d6a1c5bb | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 8 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | 20210901 |
| a66eecf9-2d8b-4e2d-8a05-d718dcbc3542 | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 4 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960 | 20251008 |
| 007728fc-f4cb-d519-e063-6394a90ae033 | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 4 | ATROPINE SULFATE INJECTION USP 0.4mg/mL | 20240122 |
| 7d8fc6fd-1eb5-30b6-e053-2a91aa0aa9f0 | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 4 | ATROPINE SULFATE INJECTION, USP 0.4mg/mL 1mL VIAL | 20221209 |
| a6fac578-c7bc-4b3c-a454-7889cc819118 | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 3 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960 | 20240704 |
| b753894e-81f8-4e81-b07a-c338311ded5b | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION . ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | 20251027 |
| bfc93de4-f731-31fa-e053-2a95a90aadcb | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | 20230427 |
| 3fa81939-4495-28d5-e063-6394a90a1f2d | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960 | 20250925 |
| 3eef6300-9c78-82b2-e063-6294a90a5499 | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960 | 20250916 |
| 09d086f2-db9a-5e15-e063-6394a90abe18 | atropine sulfate 0.4 MG in 1 ML Injection [PSN] · 1 ML atropine sulfate 0.4 MG/ML Injection [SCD] · atropine sulfate 0.4 MG per 1 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | 20231110 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| b753894e-81f8-4e81-b07a-c338311ded5b | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION . ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | Henry Schein, Inc | 20251027 |
| d5e07279-48ca-4f83-9633-299e65a7f821 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 20251020 |
| a66eecf9-2d8b-4e2d-8a05-d718dcbc3542 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960 | Hikma Pharmaceuticals USA Inc. | 20251008 |
| 3fa81939-4495-28d5-e063-6394a90a1f2d | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960 | Medical Purchasing Solutions, LLC | 20250925 |
| 3eef6300-9c78-82b2-e063-6294a90a5499 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960 | ProPharma Distribution | 20250916 |
| d5e07279-48ca-4f83-9633-299e65a7f821 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 20250228 |
| 2eb646c5-8f92-4762-9217-f0a8b6173b4f | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION.ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | Henry Schein, Inc. | 20241014 |
| b753894e-81f8-4e81-b07a-c338311ded5b | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION . ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | Henry Schein, Inc | 20240822 |
| a6fac578-c7bc-4b3c-a454-7889cc819118 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE injection, for intravenous use Initial U.S. Approval: 1960 | Somerset Therapeutics, LLC | Somerset Therapeutics Limited | 20240704 |
| 007728fc-f4cb-d519-e063-6394a90ae033 | ATROPINE SULFATE INJECTION USP 0.4mg/mL | HF Acquisition Co LLC, DBA HealthFirst | 20240122 |
| 09d086f2-db9a-5e15-e063-6394a90abe18 | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | Medical Purchasing Solutions, LLC | 20231110 |
| 78e42769-061f-4973-ac3a-dc3fcc4bf641 | ATROPINE SULFATE INJECTION, USP | American Regent, Inc. | 20230824 |
| 6ba4d3c9-44ce-97f6-e053-2a91aa0a2f88 | ATROPINE SULFATE INJECTION, USP | Medical Purchasing Solutions, LLC | 20230605 |
| bfc93de4-f731-31fa-e053-2a95a90aadcb | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | Medical Purchasing Solutions, LLC | 20230427 |
| f87f7e0b-8ad1-406a-95de-883f831eed7d | Atropine Sulfate 0.4 mg/mL Injection, USP 1 mL Single Dose Vial | Henry Schein, Inc. | 20221230 |
| 350dcd54-857d-4a65-9fd0-ad54f090fd7b | Atropine Sulfate 0.4 mg/mL Injection, USP 1 mL Single Dose Vial | General Injectables & Vaccines, Inc | 20221209 |
| 7d8fc6fd-1eb5-30b6-e053-2a91aa0aa9f0 | ATROPINE SULFATE INJECTION, USP 0.4mg/mL 1mL VIAL | HF Acquisition Co LLC, DBA HealthFirst | 20221209 |
| 6fee1727-52b7-4f73-ab45-ef47d6a1c5bb | These highlights do not include all the information needed to use ATROPINE SULFATE INJECTION safely and effectively. See full prescribing information for ATROPINE SULFATE INJECTION. ATROPINE SULFATE INJECTION, for intravenous use Initial U.S. Approval: 1960 | American Regent, Inc. | 20210901 |
| 22b968d0-d806-4104-93fc-fc6b49bd4dd8 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | S01FA | Anticholinergics | ATC1-4 | atropine | |
| ATC | A03BA | Belladonna alkaloids, tertiary amines | ATC1-4 | atropine | |
| FDASPL | N0000175574 | Anticholinergic | EPC | has_epc | atropine |
| FDASPL | N0000175700 | Cholinergic Muscarinic Antagonist | EPC | has_epc | atropine |
| FDASPL | N0000175370 | Cholinergic Antagonists | MOA | has_moa | atropine |
| FDASPL | N0000000125 | Cholinergic Muscarinic Antagonists | MOA | has_moa | atropine |
| MEDRT | D001285 | Atropine | CHEM | has_ingredient | atropine |
| MEDRT | D001285 | Atropine | CHEM | has_ingredient | atropine sulfate |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | atropine |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | atropine sulfate |
| MEDRT | D001919 | Bradycardia | DISEASE | may_treat | atropine |
| MEDRT | D001919 | Bradycardia | DISEASE | may_treat | atropine sulfate |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | ci_with | atropine |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | ci_with | atropine sulfate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | atropine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | atropine sulfate |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | atropine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | atropine sulfate |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | atropine |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | atropine sulfate |
| MEDRT | D006323 | Heart Arrest | DISEASE | may_treat | atropine |
| MEDRT | D006323 | Heart Arrest | DISEASE | may_treat | atropine sulfate |
| MEDRT | D006327 | Heart Block | DISEASE | ci_with | atropine sulfate |
| MEDRT | D006327 | Heart Block | DISEASE | ci_with | atropine |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | atropine |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | atropine sulfate |
| MEDRT | D007499 | Iris Diseases | DISEASE | ci_with | atropine |
| MEDRT | D007499 | Iris Diseases | DISEASE | ci_with | atropine sulfate |
| MEDRT | D007674 | Kidney Diseases | DISEASE | ci_with | atropine sulfate |
| MEDRT | D007674 | Kidney Diseases | DISEASE | ci_with | atropine |
| MEDRT | D007905 | Lens Diseases | DISEASE | ci_with | atropine sulfate |
| MEDRT | D007905 | Lens Diseases | DISEASE | ci_with | atropine |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | atropine sulfate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | atropine |
| MEDRT | D008532 | Megacolon, Toxic | DISEASE | ci_with | atropine sulfate |
| MEDRT | D008532 | Megacolon, Toxic | DISEASE | ci_with | atropine |
| MEDRT | D009157 | Myasthenia Gravis | DISEASE | ci_with | atropine sulfate |
| MEDRT | D009157 | Myasthenia Gravis | DISEASE | ci_with | atropine |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | atropine |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | atropine sulfate |
| MEDRT | D011041 | Poisoning | DISEASE | may_treat | atropine sulfate |
| MEDRT | D011041 | Poisoning | DISEASE | may_treat | atropine |
| MEDRT | D012848 | Sinoatrial Block | DISEASE | may_treat | atropine sulfate |
| MEDRT | D012848 | Sinoatrial Block | DISEASE | may_treat | atropine |
| MEDRT | D013276 | Stomach Ulcer | DISEASE | may_treat | atropine sulfate |
| MEDRT | D013276 | Stomach Ulcer | DISEASE | may_treat | atropine |
| MEDRT | D013610 | Tachycardia | DISEASE | ci_with | atropine sulfate |
| MEDRT | D013610 | Tachycardia | DISEASE | ci_with | atropine |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | ci_with | atropine |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | ci_with | atropine sulfate |
| MEDRT | D000267 | Tissue Adhesions | DISEASE | ci_with | atropine |
| MEDRT | D000267 | Tissue Adhesions | DISEASE | ci_with | atropine sulfate |
| MEDRT | D014517 | Ureteral Obstruction | DISEASE | ci_with | atropine |
| MEDRT | D014517 | Ureteral Obstruction | DISEASE | ci_with | atropine sulfate |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | atropine |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | atropine sulfate |
| MEDRT | D014987 | Xerostomia | DISEASE | induces | atropine sulfate |
| MEDRT | D014987 | Xerostomia | DISEASE | induces | atropine |
| MEDRT | N0000000125 | Cholinergic Muscarinic Antagonists | MOA | has_moa | atropine |
| MEDRT | N0000000125 | Cholinergic Muscarinic Antagonists | MOA | has_moa | atropine sulfate |
| MEDRT | N0000008779 | Decreased Parasympathetic Acetylcholine Activity | PE | has_pe | atropine |
| MEDRT | N0000008779 | Decreased Parasympathetic Acetylcholine Activity | PE | has_pe | atropine sulfate |
| MEDRT | N0000008868 | Decreased Respiratory Secretions | PE | has_pe | atropine |
| MEDRT | N0000008868 | Decreased Respiratory Secretions | PE | has_pe | atropine sulfate |
| MEDRT | N0000009808 | Positive Chronotropy | PE | has_pe | atropine |
| MEDRT | N0000009808 | Positive Chronotropy | PE | has_pe | atropine sulfate |
| MEDRT | N0000009820 | Pupillary Dilation | PE | has_pe | atropine |
| MEDRT | N0000009820 | Pupillary Dilation | PE | has_pe | atropine sulfate |
| MEDRT | N0000009842 | Salivation Inhibition | PE | has_pe | atropine sulfate |
| MEDRT | N0000009842 | Salivation Inhibition | PE | has_pe | atropine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.4 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | QUANTITY | 1 ML |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA215969 |
| CODES | ANDA | ANDA216120 |
| CODES | ANDA | ANDA217345 |
| CODES | NDA | NDA214652 |
| CODES | VUID | 4000625 |
| NAMES | Prescribable Synonym | atropine sulfate 0.4 MG in 1 ML Injection |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |